Results 41 to 50 of about 3,057,829 (262)

Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance [PDF]

, 2004
Drug-resistant tuberculosis can be transmitted (primary) or develop during the course of treatment (secondary). We investigated risk factors for each type of resistance.
Glynn, JR, Story, A, Hayward, AC, Watson, JM, Conaty, SJ, Drobniewski, FA   +5 more
core   +1 more source

Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis [PDF]

Cold Spring Harbor Perspectives in Medicine, 2015
The continuing spread of drug-resistant tuberculosis (TB) is one of the most urgent and difficult challenges facing global TB control. Patients who are infected with strains resistant to isoniazid and rifampicin, called multidrug-resistant (MDR) TB, are practically incurable by standard first-line treatment.
Kwonjune J, Seung, Salmaan, Keshavjee, Michael L, Rich   +2 more
openaire   +2 more sources

Plasma drug activity assay for treatment optimization in tuberculosis patients [PDF]

, 2011
Item does not contain fulltextLow antituberculosis (TB) drug levels are common, but their clinical significance remains unclear, and methods of measurement are resource intensive.
Scott K. Heysell, Mpagama, S., Kibiki, Gibson S, Houpt, Eric R, Mwaigwisya, S., Heysell, Scott K, Ndusilo, Norah, Pholwat, Suporn, Mwaigwisya, Solomon, Kibiki, G.S., Solomon Mwaigwisya, Suporn Pholwat, Jean Gratz, Mtabho, C., Aarnoutse, R.E., Stellah Mpagama, Heysell, S.K., Rob E. Aarnoutse, Charles Mtabho, Gratz, J., Mpagama, Stellah, Norah Ndusilo, Gratz, Jean, Houpt, E.R., Gibson S. Kibiki, Eric R. Houpt, Mtabho, Charles, Aarnoutse, Rob E, Ndusilo, N., Pholwat, S.   +29 more
core   +1 more source

Prevalence of Extensively Drug-Resistant Tuberculosis: a Descriptive Study

Эпидемиология и вакцинопрофилактика, 2018
Background. Extensively drug-resistant tuberculosis (XDR-TB) is a threat to community health. Goal. The estimation of the prevalence of extensively drug-resistant tuberculosis in Omsk region, along with the clinical and epidemiological description of ...
O. A. Pasechnik, A. A. Zimoglyad, I. V. Yarusova, S. V. Vitriv, A. I. Blokh   +4 more
doaj   +1 more source

Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs. [PDF]

, 2011
BACKGROUND: Sudan is a large country with a diverse population and history of civil conflict. Poverty levels are high with a gross national income per capita of less than two thousand dollars.
Bottomley, Christian, McNerney Ruth, Ali Ahmed B, Salih, Abdel Latif Ga, McNerney, Ruth, Mohammed S Ali, Ruth McNerney, Fadl-Elmula, Imad, Christian Bottomley, Ali, Ahmed B, Ghada S Sharaf Eldin, Imad Fadl-Elmula, Ali, Mohammed S, Mallard, Kim, Abdel Latif GA Salih, Bottomley Christian, Ahmed B Ali, Salih Abdel Latif GA, Fadl-Elmula Imad, Sharaf Eldin, Ghada S, Ali Mohammed S, Kim Mallard, Sharaf Eldin Ghada S, Mallard Kim   +23 more
core   +2 more sources

Second-line drug resistance among multidrug-resistant tuberculosis patients in Ethiopia: A laboratory-based surveillance

Journal of Global Antimicrobial Resistance
Objectives: To estimate the proportion of second-line anti-tuberculosis drug resistance among multidrug-resistant tuberculosis (MDR-TB) patients in Ethiopia.
Getu Diriba, Ayinalem Alemu, Bazezew Yenew, Betselot Zerihun Ayano, Michael Hailu, Bedo Buta, Amanuel Wondimu, Zigba Tefera, Abyot Meaza, Getachew Seid, Muluwork Getahun, Biniyam Dagne, Hilina Mollalign, Yeshiwork Abebaw, Melak Getu, Mengistu Tadesse, Tegegn Belhu, Ephrem Alemu, Minilik Demissie, Ashenafi Erresso, Getachew Aga, Andargachew Kumsa, Taye Letta, Saro Abdella, Shewki Moga, Mesay Hailu Dangisso, Getachew Tollera, Gemechu Tadesse   +27 more
doaj   +1 more source

Issues of Tuberculosis Drug-Resistance in Kharkiv Region and in Ukraine

Infusion & Chemotherapy, 2019
Background. Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis remain severe epidemic problems in the world. That’s why the purpose of our study was to investigate the dynamics of the incidence of multidrug-resistant and ...
O.S. Shevchenko, O.O. Pohorielova
doaj   +1 more source

Extensive Drug Resistance in Malaria and Tuberculosis

Emerging Infectious Diseases, 2010
Drug resistance in malaria and in tuberculosis (TB) are major global health problems. Although the terms multidrug-resistant TB and extensively drug-resistant TB are precisely defined, the term multidrug resistance is often loosely used when discussing malaria.
Chansuda Wongsrichanalai, Jay K. Varma, Jonathan J. Juliano, Michael E. Kimerling, John R. MacArthur   +4 more
openaire   +3 more sources

Survival of Civilian and Prisoner Drug-Sensitive, Multi- and Extensive Drug- Resistant Tuberculosis Cohorts Prospectively Followed in Russia [PDF]

, 2011
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
Rutterford, CM, Shakhmistova Anastasiya, Nadezhda Malomanova, Malomanova Nadezhda, Nikolayevskyy, V, Malomanova, N, Ignatyeva, O, Rutterford Clare M., Mironova Svetlana, Yulia Chinkova, Mironova, S, Anastasiya Shakhmistova, Vladyslav Nikolayevskyy, Francis A. Drobniewski, Balabanova Yanina, Irina Kontsevaya, Drobniewski, FA, Chinkova, Y, Kontsevaya, I, Olga Ignatyeva, Clare M Rutterford, Chinkova Yulia, Francis A Drobniewski, Balabanova, Y, Shakhmistova, A, Fedorin, I, Yanina Balabanova, Ignatyeva Olga, Nikolayevskyy Vladyslav, Ivan Fedorin, Fedorin Ivan, Svetlana Mironova, Drobniewski Francis A., Clare M. Rutterford, Kontsevaya Irina   +34 more
core   +2 more sources

The Efficacy of the Crude Root Bark Extracts of Erythrina Abyssinica on Rifampicin Resistant Mycobacterium Tuberculosis. [PDF]

, 2011
Tuberculosis (TB) is one of the leading causes of morbidity and mortality with a global mortality rate at two million deaths per year while one third of the world's population is infected with the TB bacillus.
Orodho, J.A., Bunalema, L, Bunalema, L., Kirimuhuzya, C., Orodho, J A, Tabuti, J.R., Kirimuhuzya, C, Magadula, J J, Otieno, N., Okemo, P, Otieno, N, Tabuti, JRS, Orodho, JA, Magadula, J.J., Waako, P., Tabuti, J R S, Waako, P, Magadula, JJ   +17 more
core   +1 more source